IL-17A Levels in Cystic Fibrosis Patients
Author Information
Author(s): Ann Decraene, Anna Willems-Widyastuti, Ahmad Kasran, Kris De Boeck, Dominique M Bullens, Lieven J Dupont
Primary Institution: KULeuven, Belgium
Hypothesis
IL-17A might be partly responsible for neutrophilic inflammation in the airways of cystic fibrosis patients.
Conclusion
Elevated levels of IL-17 and IL-23 suggest that Th17 cells are involved in the persistent neutrophil infiltration in cystic fibrosis lung disease.
Supporting Evidence
- IL-17A protein and mRNA levels were significantly higher in CF patients compared to healthy controls.
- Patients chronically infected with Pseudomonas aeruginosa had higher IL-17 and IL-23 mRNA levels.
- No correlation was found between IL-17 or IL-23 levels and lung function (FEV1).
Takeaway
This study found that cystic fibrosis patients have higher levels of certain proteins that can cause inflammation in their lungs, which might make their condition worse.
Methodology
Sputum induction was performed in adult CF patients and healthy controls, followed by measurement of IL-17A protein and mRNA levels using cytometric bead array and quantitative RT-PCR.
Potential Biases
Potential selection bias as all recruited patients were adults with established lung disease.
Limitations
The study was limited to adult patients and did not include children or those with exacerbations.
Participant Demographics
38 stable adult CF patients and 11 healthy controls; mean age of CF patients was approximately 26 years.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website